The company references weight-loss outcomes associated with semaglutide, including a figure of "15-20% average body weight loss." Those figures are tied to broader clinical literature about FDA-approved branded semaglutide products studied in formal clinical trials and should not be interpreted as established outcomes for the compounded formulations dispensed through this telehealth platform
What Human Evidence Did FDA Review
While probiotics are generally considered safe, there may always be an inherent risk when taking any food supplement, says Planells
This skinny shot uses a medication called Semaglutide which mimics a natural protein found in your body called GLP-1
Cross-contamination between vials, while unlikely with proper technique, represents a risk that increases with protocol complexity
Nevertheless, promising results from preclinical trials and the TODINELI-trial promote the idea of investigating the protective effects of GLP-1R agonists on neuropathy in further clinical trials